AMGEN INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12,568 ARS | -1.15% |
|
-5.90% | +34.65% |
| 06-14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
| 06-14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 791B | ||||||
| 630B | ||||||
| 328B | ||||||
| 298B | ||||||
| 246B |
